17-4899337-GGGC-GGGCGGC

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PM4_Supporting

The NM_000080.4(CHRNE):​c.1077_1079dupGCC​(p.Pro360dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00039 in 1,547,780 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P360P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00054 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00037 ( 0 hom. )

Consequence

CHRNE
NM_000080.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 0.170

Publications

0 publications found
Variant links:
Genes affected
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
C17orf107 (HGNC:37238): (chromosome 17 open reading frame 107)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_000080.4. Strenght limited to Supporting due to length of the change: 1aa.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000080.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNE
NM_000080.4
MANE Select
c.1077_1079dupGCCp.Pro360dup
disruptive_inframe_insertion
Exon 10 of 12NP_000071.1
C17orf107
NM_001145536.2
MANE Select
c.-426_-425insGGC
upstream_gene
N/ANP_001139008.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNE
ENST00000649488.2
MANE Select
c.1077_1079dupGCCp.Pro360dup
disruptive_inframe_insertion
Exon 10 of 12ENSP00000497829.1
CHRNE
ENST00000649830.1
c.144_146dupGCCp.Pro49dup
disruptive_inframe_insertion
Exon 10 of 11ENSP00000496907.1
CHRNE
ENST00000572438.1
TSL:5
n.763_765dupGCC
non_coding_transcript_exon
Exon 5 of 7

Frequencies

GnomAD3 genomes
AF:
0.000527
AC:
80
AN:
151852
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.0286
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.000778
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000515
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000361
AC:
53
AN:
146728
AF XY:
0.000368
show subpopulations
Gnomad AFR exome
AF:
0.000270
Gnomad AMR exome
AF:
0.000208
Gnomad ASJ exome
AF:
0.00100
Gnomad EAS exome
AF:
0.000355
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000407
Gnomad OTH exome
AF:
0.000237
GnomAD4 exome
AF:
0.000373
AC:
521
AN:
1395812
Hom.:
0
Cov.:
35
AF XY:
0.000392
AC XY:
271
AN XY:
690526
show subpopulations
African (AFR)
AF:
0.000189
AC:
6
AN:
31714
American (AMR)
AF:
0.000168
AC:
6
AN:
35786
Ashkenazi Jewish (ASJ)
AF:
0.00136
AC:
34
AN:
25046
East Asian (EAS)
AF:
0.000275
AC:
10
AN:
36414
South Asian (SAS)
AF:
0.000446
AC:
36
AN:
80672
European-Finnish (FIN)
AF:
0.0000265
AC:
1
AN:
37788
Middle Eastern (MID)
AF:
0.000394
AC:
2
AN:
5072
European-Non Finnish (NFE)
AF:
0.000358
AC:
389
AN:
1085262
Other (OTH)
AF:
0.000637
AC:
37
AN:
58058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
30
60
90
120
150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000540
AC:
82
AN:
151968
Hom.:
0
Cov.:
32
AF XY:
0.000619
AC XY:
46
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41468
American (AMR)
AF:
0.000131
AC:
2
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.000780
AC:
4
AN:
5130
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10574
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000515
AC:
35
AN:
67908
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000391
Hom.:
0
Bravo
AF:
0.000699
Asia WGS
AF:
0.00115
AC:
4
AN:
3476

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Jan 23, 2025
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 23, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In-frame insertion of 1 amino acids in a non-repeat region; Has not been previously published as pathogenic or benign to our knowledge

Nov 13, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital myasthenic syndrome Uncertain:2
Jan 17, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 14, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Congenital myasthenic syndrome 4A Uncertain:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.1077_1079dup, results in the insertion of 1 amino acid(s) of the CHRNE protein (p.Pro360dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752226476, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 465852). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Congenital myasthenic syndrome 4C;C4225369:Congenital myasthenic syndrome 4B;C4225413:Congenital myasthenic syndrome 4A Uncertain:1
Jul 28, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.17
Mutation Taster
=81/19
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs752226476; hg19: chr17-4802632; API